{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:42:57Z","timestamp":1782736977354,"version":"3.54.5"},"reference-count":38,"publisher":"Informa UK Limited","issue":"5","funder":[{"name":"Ruth L. Kirschstein NRSA Institutional Training","award":["2T32 CA06039611"],"award-info":[{"award-number":["2T32 CA06039611"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,5,4]]},"DOI":"10.1080\/17425255.2018.1461838","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T15:27:16Z","timestamp":1522942036000},"page":"543-550","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacokinetic drug evaluation of niraparib for the treatment of ovarian cancer"],"prefix":"10.1080","volume":"14","author":[{"given":"Teresa C.","family":"Longoria","sequence":"first","affiliation":[{"name":"University of California, Irvine Medical Center, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnansu S.","family":"Tewari","sequence":"additional","affiliation":[{"name":"University of California, Irvine Medical Center, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-suppl_5-20"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0505"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30279-6"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4489"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0714"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/nature10166"},{"key":"CIT0007","volume-title":"Approved drugs, olaparib"},{"key":"CIT0008","volume-title":"Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats. Bethesda"},{"key":"CIT0009","volume-title":"Approved drugs, rucaparib"},{"key":"CIT0010","volume-title":"A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)"},{"key":"CIT0011","volume-title":"A study of oral rucaparib in patients with a solid tumor (phase i) or with gBRCA mutation ovarian cancer (Phase II)"},{"key":"CIT0012","volume-title":"Approved drugs, Niraparib (ZEJULA)"},{"key":"CIT0013","volume-title":"A maintenance study with niraparib versus placebo in patients with platinum sensitive ovarian cancer"},{"key":"CIT0014","volume-title":"Approved drugs, FDA approves olaparib tablets for maintenance treatment in ovarian cancer"},{"key":"CIT0015","volume-title":"Assessment of efficacy of AZD2281 in platinum sensitive relapsed serous ovarian cancer"},{"key":"CIT0016","unstructured":"Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy Bethesda, MA: U.S. National Institute of Health [cited 2017 Aug 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01874353"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.03.505"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx440.034"},{"key":"CIT0019","volume-title":"ZEJULA (niraparib) prescribing information"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1021\/jm901188v"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1021\/jm5018237"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2753"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70240-7"},{"key":"CIT0026","volume":"28","author":"Zhang ZY","year":"2017","journal-title":"Ann Oncol"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3512-5"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx372.004"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1200\/JCO.2017.35.15_suppl.5560","volume":"35","author":"Campo JMD","year":"2017","journal-title":"J Clin Oncol"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1200\/JCO.2017.35.15_suppl.5517","volume":"35","author":"Mirza MR","year":"2017","journal-title":"J Clin Oncol"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx372"},{"key":"CIT0033","first-page":"XX","volume":"145","author":"Mahner S","year":"2017","journal-title":"Gynecol Oncol"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2017.35.15_suppl.5534","volume":"35","author":"Matulonis UA","year":"2017","journal-title":"J Clin Oncol"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx372.003"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx372.024"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx376.009"},{"key":"CIT0038","author":"Konstantinopoulos PA, Munster P, Forero-Torres A","journal-title":"SGO Annual Meeting; March 24\u201327, 2018, New Orleans, LA. Late-Breaking Abstract"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1461838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T05:08:29Z","timestamp":1571029709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1461838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2018,5,4]]}},"alternative-id":["10.1080\/17425255.2018.1461838"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1461838","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}